The human multidrug resistance gene (MDR1) is encoding the transmembrane transporter p-glycoprotein (p-gp) which plays an important role in the efflux of various drugs and thus is potentially influencing the drug-treatment outcome. It has been indicated that the level of p-gp activity may be affected by the presence of single nucleotide polymorphisms (sNp) in the gene which led to the studies estimating MDR1-sNp frequencies in various populations. Here, we have investigated the occurrence of seven sNp in the MDR1 gene for the first time in slovak population using multiplex sNapshot genotyping method. The allelic frequencies of the most common gene variants, i.e. 1236C>T, 2677G>T, 2677G>a and 3435C>T were estimated to be 42.5%, 43.5%, 2%, and 44.5%, respectively. We found that the most prevalent haplotype in slovak population is 1236C-2677G-3435C occurring in 42.2% of individuals. our preliminary data show that it is reasonable and feasible to utilize MDR1 genotypes and haplotypes in slovak patients, e.g. those with acute myeloid leukemia, in order to adjust the individual effective drug dosage and predict the patient's response to the treatment as well as the treatment outcome.
The p-glycoprotein (p-gp) is a large transmembrane energydependent transporter with important role in drug efflux. p-gp was found to be expressed in most of blood-tissue barriers, liver, kidneys, intestine, blood-brain barrier, endothelium, placenta, ovaries, testes and salivary glands [1] [2] [3] . The substrate specificity of p-gp is surprisingly wide, including pharmacologically distinct agents, i.e. anticancer, antihypertensive agents, antiarrythmics, glucocorticoids, antiviral drugs, antibiotics, immunosuppressants, antidepressants, neuroleptics, antiepileptics, antiacids, opioids and others [3] . The tissue localization and the broad substrate specificity suggest the importance of p-gp in absorption, distribution and excretion of many drugs [4] [5] [6] .
p-gp is encoded by the human multidrug resistance 1 (MDR1) gene which was localized on 7p21.1 chromosome, comprises of 28 exons [7] and gives rise to a 4.5 kb mRNa. The first systematic study on single nucleotide polymorphisms (sNp) in the gene revealed 15 different variants and also for the first time showed that sNp may affect expression levels and in vivo activity of the p-gp [8] . This finding stimulated the screening for other polymorphisms in the gene and studies on their manifestation on RNa and/ or protein level. Today more than 100 sNp are known in the MDR1 gene (http://www.ncbi.nlm.nih.gov/sNp/) but most of them are silent, occur at very low frequencies or are located in intronic sequences.
The three most frequent polymorphisms in Caucasian population are 1236C>T, 2677G>T/a, and 3435C>T [9] . The 3435C>T substitution was the first silent sNp in the MDR1 gene for which the effect on the p-gp expression level has been demonstrated despite the fact that it is located at a wobble position and does not change the amino acid sequence. a significant inverse correlation of the 3435 sNp has been observed with the p-gp activity in vivo; the individuals homozygous for the T-allele had the high detectable digoxin concentration in comparison to homozygotes for the C-allele displaying the low level of drug [8] . The effect of the 3435C>T change has been confirmed also in subsequent studies in which it caused alteration in digoxin [10] , fexofenadine [11, 12] and cyclosporine levels [13, 14] . The other silent sNp in position 1236 with the CC reference genotype has been associated with lower peak drug concentration and reduced drug exposure when compared to the T allele carriers [15] . From the three most common polymorphisms the 2677C>T/A is the only one changing the protein primary structure and interestingly can result in two distinct amino acids, Ala893Ser (2677G>T) and Ala893Thr (2677G>A). It has been shown that the genotype variations had substrate-dependent effect in cellular system, affected the mRNA level and increased drug efflux [16, 17] . Published data also imply that this SNP may influence the time to relapse and overall survival from relapse/refractory disease in AML (Acute myeloid leukemia) patients [18, 19] . For the 3435 SNP contradictory results were found in different studies, some of them finding lower P-gp expression in 3435TT homozygotes, while other showing higher or no change in protein activity for the same genotype [3, [20] [21] [22] .
Multiple studies have demonstrated that linkage disequilibrium exists between the 2677 and 3435 SNP suggesting that the haplotype evaluation might be better in predicting the functional effects. In agreement with this, several studies have already demonstrated that the pharmacokinetics predictions based on haplotype analysis are superior to the genotyping of individual SNP [22] [23] [24] . Subsequently, numbers of studies were dealing with evaluation of the MDR1 genotype and haplotype frequencies in various populations using different genotyping techniques. In our study we analyzed MDR1 gene polymorphisms and haplotypes in healthy subjects from Slovak population using SNaPshot Multiplex System with the aim to estimate the allelic and haplotype frequencies of this gene and compare the obtained data with other populations.
Materials and methods
Samples. Hundred unrelated healthy Slovak individuals were involved in this study. Genomic DNA was extracted from 200 μl of peripheral blood sample using QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) following the manufacturer's protocol.
Multiplex PCR amplification of targets. Targets containing seven SNP listed in Table 1 were amplified in a five genomic segments ( Figure 1 ) in a single multiplex PCR reaction using five pairs of primers ( Table 2 ). Some of these primers were identical to those published previously [25] . The PCR reaction contained primers in a range from 0.15 μmol/l to 1.2 μmol/l, 12.5 μl of Multiplex PCR Master Mix (Qiagen, Hilden, Germany) and 100 ng DNA template in a final reaction volume of 25 μl. The reaction mixtures were subjected to initial denaturation at 94 °C for 15 min followed by 40 stepcycles of denaturation at 94 °C for 30 s, annealing at 56 °C for 30 s, extension at 72 °C for 1 min, and final extension at 72 °C for 5 min. The PCR products were purified by the enzymatic treatment with 10 U of Exonuclease I (Fermentas, Hanover, USA) and 1 U of SAP (Promega, Madison, USA) at 37 °C for 15 min and enzymes were subsequently inactivated at 80 °C for 15 min.
Single-base extension of SNP-specific primers. For the MDR1-SNP genotyping, we performed single base extension of 7 SNP-specific primers using ABI PRISM ® SNaPshot ® Multiplex Kit (Applied Biosystems, Foster City, USA). The SNP specific oligonucleotides (characterized in Table 3 ) were adopted from previously published study [25] . These primers consisted of a specific sequence (19-24 nucle- Statistical analysis. Statistical significance (P < 0.05) was assessed by χ2 test for two degrees of freedom. Expected distribution of genotypes was calculated by Hardy-Weinberg equilibrium. The haplotypes were calculated using the Estimate Haplotype (EH) (Jurg Ott, Rockefeller University, New York) program based on the observed frequencies of the 1236C>T, 2677G>T/A and 3435C>T. Linkage disequilibrium (LD) between these three loci was found, resulting in the frequency differences between our results and haplotypes expected in case of lack of such an association (Table 6) .
Results and Discussion
The MDR1 is highly polymorphic gene spanning over 200 kb in human genome, however only a couple of the SNP located in the exonic sequence occur at high frequency. Thus, most of the studies are oriented towards elucidating the impact of these few polymorphisms on P-gp expression, function and also the drug-response of treated patients. In our study we have investigated the frequencies of seven MDR1-SNPloci including the three most common SNP as well as related haplotypes in Slovak population. Figure 2 shows representative electrophoretograms from multiplex SNaPshot analyses of investigated SNP. In the three loci, -41A>G, -145C>G and -129T>C, all of the individuals were homozygous for wildtype allele and in the 4036A>G SNP, only few subjects were heterozygous. Therefore, we present only the data from highly heterozygous SNP in the Table 4 . All of the observed genotype frequencies did not show significant deviation from the expected frequencies as calculated by Hardy-Weinberg equilibrium and all of the expected allelic frequencies are within the 95% confidence interval (CI). In the next, we focus on description of individual SNP that were highly polymorphic in Slovak population.
1236C>T: In a group of studied individuals, 35% (n=35) were homozygous for C allele, 20% (n=20) for T, and 45% (n=45) were CT heterozygotes. When comparing within other Caucasian populations, these allele frequencies are closest to those of German population [9] . For this silent polymorphism, the effect on the cyclosporine pharmacokinetic parameters was described previously pointing out a weak association between dose-adjusted C max and dose adjusted AUC 0-4 with the wild-type genotype, these parameters respectively being 16% and 14% lower in wild-type than in mutated allele carriers [15] .
2677G>T/A: The most common genotype in the nucleotide position at 2677 of MDR1 gene in our cohort was GT appearing in 43% (n=43), followed by GG in 32% (n=32) and TT in 21% (n=21) of individuals. We also identified four carriers of the rare A allele, two (2%) of them were TA and other two (2%) GA heterozygotes. This allele distribution is similar to that found in German or Russian population [9, 26] . Studies investigating the role of this SNP revealed its effect on the RNA level, further on the interaction between P-gp transporter and the substrate as well as on drug efflux [16, 17, 27] . Interestingly, it has been reported that this SNP is influencing the time to relapse and overall survival from relapse / refractory disease in AML patients [18, 19] .
3435C>T: This was the very first silent SNP for which the effect on the P-gp protein level was clearly exhibited that led subsequently to the ever increasing interest on other SNP in the MDR1 gene. The distribution of genotypes in our group was 33% (n=33), 45% (n=45) and 22% (n=22) for CC, CT and TT, respectively. Since this is the most studied SNP in the MDR1 gene, the allele and genotype frequencies for various populations from around the world are known. The comparisons of these frequencies with our data are given in Table 5 . The occurrence of this SNP differs within Caucasians with the range from 38% in Polish population [28] to 59% in Russian population [29] . It seems that the frequencies of genotypes at 3435 are rather consistent within individual races. As evident from Table 5 , African population has a highest frequency of the C allele, up to 83% in Ghanaians. It is assumed that this high frequency is a consequence of natural selections resulting from selective advantage against gastrointestinal tract infections [30] .
Haplotype analysis: As the superiority of haplotype analysis had been demonstrated in several studies [22] [23] [24] , we also have estimated the haplotyope frequencies using the Estimate Haplotype (EH) program [31] . For the 2677-3435 haplotype, all six alternatives were present with the highest frequency for the 2677G-3435C (45.7%) followed by the 2677T-3435T (33.5%) and the rarest identified haplotype was the 2677A-3435T (0.02%). Obtained frequencies are comparable with those found in the most other Caucasian populations except the Germans where only four haplotypes were reported [22] . The haplotype frequencies are significantly different in African-American and Beninese population where the 2677G-3435C haplotype is present in 78.3% and 85.3% subjects, respectively. Only four haplotypes seem to exist in Beninese [32] and five in African-American population [33] . Recently published paper described the effect of the 2677G-3435T haplotype on AUC value after oral digoxin administration and also emphasized the notion that haplotype analysis was superior to considering only one SNP in the evaluation of the impact on P-gp phenotype [22] . We also evaluated haplotype frequencies for the 1236-2677-3435 loci. Ten from all twelve possible combinations were observed ( [34] and Caucasians, but in contrast to eight present in African-American [35] and only six occurring in Benineses [32] . The two major haplotypes observed were 1236C-2677G-3435C (42.2%) and 1236T-2677T-3435T (30.2%). The most frequent haplotype in Slovak population is also predominant in the Beninese (79.3%) and African-American (72.6%) populations [35] . It has been reported that the 1236C-2677G-3435C haplotype was associated with decreased overall survival and high probability of relapse in AML patients [36] .
In conclusion, to our knowledge, the study we conducted represents the first attempt to estimate the frequencies of polymorphisms and haplotypes in the MDR1 gene in Slovak population. The results reported here add to the data collected on SNP frequencies and haplotypes in this gene world-wide. They also show that in the future it is reasonable and feasible to perform the analysis of the MDR1-SNP in the Slovak pa- 
